These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1972733)

  • 21. Dopamine released from dendrites in the substantia nigra controls the nigral and striatal release of serotonin.
    Hery F; Soubrie P; Bourgoin S; Motastruc JL; Artaud F; Glowinski J
    Brain Res; 1980 Jul; 193(1):143-51. PubMed ID: 6247027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is the release of dopamine from medial prefrontal cortex modulated by presynaptic receptors? Comparison with nigrostriatal and mesolimbic terminals.
    Cubeddu LX; Hoffmann IS; Talmaciu RK
    Ann N Y Acad Sci; 1990; 604():452-61. PubMed ID: 2171402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of unilateral electrical stimulation of various thalamic nuclei on the release of dopamine from dendrites and nerve terminals of neurons of the two nigrostriatal dopaminergic pathways.
    Chéramy A; Chesselet MF; Romo R; Leviel V; Glowinski J
    Neuroscience; 1983 Apr; 8(4):767-80. PubMed ID: 6866262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA(A) receptors in vivo.
    Paladini CA; Celada P; Tepper JM
    Neuroscience; 1999 Mar; 89(3):799-812. PubMed ID: 10199614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Muscarinic antagonists in substantia nigra influence the decarboxylation of L-dopa in striatum.
    Izurieta-Sánchez P; Sarre S; Ebinger G; Michotte Y
    Eur J Pharmacol; 2000 Jul; 399(2-3):151-60. PubMed ID: 10884514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nigrostriatal overabundance of α-synuclein leads to decreased vesicle density and deficits in dopamine release that correlate with reduced motor activity.
    Gaugler MN; Genc O; Bobela W; Mohanna S; Ardah MT; El-Agnaf OM; Cantoni M; Bensadoun JC; Schneggenburger R; Knott GW; Aebischer P; Schneider BL
    Acta Neuropathol; 2012 May; 123(5):653-69. PubMed ID: 22361813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Excitation of rat striatal large neurons by dopamine and/or glutamate released from nerve terminals via presynaptic nicotinic receptor (A4beta2 type) stimulation.
    Matsubayashi H; Amano T; Amano H; Sasa M
    Jpn J Pharmacol; 2001 Aug; 86(4):429-36. PubMed ID: 11569617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo presynaptic control of dopamine release in the cat caudate nucleus--II. Facilitatory or inhibitory influence of L-glutamate.
    Chéramy A; Romo R; Godeheu G; Baruch P; Glowinski J
    Neuroscience; 1986 Dec; 19(4):1081-90. PubMed ID: 2881227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations in nigral NMDA and GABAA receptor control of the striatal dopamine level after repetitive exposures to nitrogen narcosis.
    Lavoute C; Weiss M; Rostain JC
    Exp Neurol; 2008 Jul; 212(1):63-70. PubMed ID: 18452916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GABA(A) receptors in the pars compacta and GABA(B) receptors in the pars reticulata of rat substantia nigra modulate the striatal dopamine release.
    Balon N; Kriem B; Weiss M; Rostain JC
    Neurochem Res; 2002 May; 27(5):373-9. PubMed ID: 12064352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine.
    Marti M; Manzalini M; Fantin M; Bianchi C; Della Corte L; Morari M
    J Neurochem; 2005 Apr; 93(1):195-205. PubMed ID: 15773919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glutamate modulates dopamine release in the striatum as measured by brain microdialysis.
    Shimizu N; Duan SM; Hori T; Oomura Y
    Brain Res Bull; 1990 Jul; 25(1):99-102. PubMed ID: 1976424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective destruction of nigrostriatal dopaminergic neurons does not alter [3H]-ryanodine binding in rat striatum.
    Noël F; Geurts M; Maloteaux JM
    Braz J Med Biol Res; 2000 Feb; 33(2):237-40. PubMed ID: 10657066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of dopamine released from distal and proximal dendrites of nigrostriatal dopaminergic neurons in the control of GABA transmission in the thalamic nucleus ventralis medialis in the cat.
    Gauchy C; Kemel ML; Desban M; Romo R; Glowinski J; Besson MJ
    Neuroscience; 1987 Sep; 22(3):935-46. PubMed ID: 3683856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of neuroleptics on the nigroneostriatal and mesocortical dopaminergic systems.
    Glowinski J
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():233-46. PubMed ID: 769114
    [No Abstract]   [Full Text] [Related]  

  • 36. Non-dopaminergic nigrostriatal pathway.
    Guyenet PG; Crane JK
    Brain Res; 1981 Jun; 213(2):291-305. PubMed ID: 7248760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of glutamate on the dopamine content and metabolism in the nigrostriatal system of rats differing by their learning capacities].
    Karpova IV; Iakimovskiĭ AF
    Fiziol Zh Im I M Sechenova; 1993 Feb; 79(2):43-51. PubMed ID: 8101122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dendritic release of dopamine in the substantia nigra.
    Cheramy A; Leviel V; Glowinski J
    Nature; 1981 Feb; 289(5798):537-42. PubMed ID: 6258083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of cortico-striatal "glutamatergic" neurons in the presynaptic control of dopamine release in the cat caudate nucleus.
    Chéramy A; Barbeito L; Romo R; Godeheu G; Glowinski J
    Clin Neuropharmacol; 1986; 9 Suppl 4():500-2. PubMed ID: 3567956
    [No Abstract]   [Full Text] [Related]  

  • 40. Regulations of the activity of the nigrostriatal dopaminergic pathways by cortical, cerebellar, and sensory neuronal afferences.
    Glowinski J; Niecoullon A; Chéramy A
    Adv Biochem Psychopharmacol; 1978; 19():75-87. PubMed ID: 358788
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.